SNWV
$0.18
Sanuwave Health
$.00
(.28%)
SNWV
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.00
Revenue:  N/A
Friday
Nov 13
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when SNWV reports earnings?
Beat
Meet
Miss

Where is SNWV's stock price going from here?
Up
Flat
Down
Stock chart of SNWV
Analysts
Summary of analysts' recommendations for SNWV
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesSeattle GeneticsBluebird BioQiagen N.V.Bio-TechneRepligenBioCryst Pharmaceuticals